Vice President, Policy & External Affairs
Believing in strong partnerships
Bringing important medicines and vaccines to people around the world through breakthrough science is at the heart of what we do at Merck. In response to a rapidly-evolving pharmaceutical industry, Merck has taken a proactive approach by transforming its research model in order to continue to deliver true innovations to patients. This new model for discovering and developing medicines has shifted from vertically integrated in-house research towards partnerships with universities, hospitals and Canadian biotechnology companies. A collaborative approach stands to benefit even more Canadian stakeholders now by including governments, universities, hospitals, entrepreneurs and investors. Discover us – come and learn about existing partnerships and future opportunities.
Jennifer Chan was appointed Vice President, Policy & External Affairs, at Merck Canada as of June 1, 2014 and is responsible for the company’s team of government relations and public affairs specialists. Prior to this role, she held the position of Vice President, Policy and Communications at Merck Canada since December 2011.
A native of Montreal, Jennifer began her career in academic research before joining Schering-Plough in 1993 as a Clinical Research Associate. Since then, she has worked in various areas of the business, primarily in Regulatory Affairs, Specialty Services and Medical Affairs. She was Director of Regulatory Affairs, for Schering Plough at the time of the merger with Merck in 2009.
Jennifer is a member of the Board of Directors of the Institute of Health Economics in Alberta, as well as the Quebec Consortium for Drug Discovery. She is a member of the Public System Committee of RX&D, Canada’s Association of Research-Based Pharmaceutical Companies. She is also a member of the board of the West Island Community Shares. Jennifer holds a Bachelor of Science degree in physiology and a Master of Science degree in pharmacology and therapeutics, both from McGill University in Montreal. She completed the last year of her master’s degree at Baylor College of Medicine in Houston, Texas.
Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women’s health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.
Based in Montréal, Québec, Merck employs approximately 775 people across Canada. Merck is one of the top R&D investors in Canada, with investments totalling $22.6 million in 2013 and more than $1 billion since 2000.